Potempa J, Enghild J J, Travis J
Department of Microbiology and Immunology, Jagiellonian University, Kraków, Poland.
Biochem J. 1995 Feb 15;306 ( Pt 1)(Pt 1):191-7. doi: 10.1042/bj3060191.
Two primary serine proteinase inhibitors in goat plasma have been isolated and characterized. The N-terminal sequence analysis of the purified proteins revealed that they are closely related to each other and are highly homologous to human alpha 1-anti-chymotrypsin rather than alpha 1-proteinase inhibitor. However, despite structural similarities the inhibitory specificity of the goat inhibitors differed from each other and from that of anti-chymotrypsin. In contrast with human anti-chymotrypsin, one of the goat inhibitors was shown to be a strong and specific inhibitor of trypsin (k(ass.) = 1.9 x 10(6) M-1.s-1), whereas the other was an efficient inhibitor of neutrophil elastase (k(ass.) = 1.5 x 10(6) M-1.S-1). Differences in the inhibitory specificity of each protein could readily be attributed to the amino acid sequence within the reactive site region. The trypsin inhibitor with an assumed arginine residue at the P1 position of the reactive-site peptide bond is referred to as 'contrapsin', and indicates that the occurrence of contrapsins is not restricted to rodents. In contrast, the inhibitory specificity, resistance to oxidative and proteolytic inactivation and the presence of a P1 leucine residue in the elastase inhibitor is unique among inhibitory serpins that have been characterized to date. Because this serpin is apparently the major elastase inhibitor in goat plasma, it is likely to be involved in the control of goat neutrophil elastase. Therefore, we suggest the name 'elastasin', and extend it to any other anti-chymotrypsin related serpins possessing neutrophil-elastase- inhibitory activity.
已从山羊血浆中分离并鉴定出两种主要的丝氨酸蛋白酶抑制剂。对纯化蛋白的N端序列分析表明,它们彼此密切相关,且与人α1-抗糜蛋白酶高度同源,而非α1-蛋白酶抑制剂。然而,尽管结构相似,山羊抑制剂的抑制特异性彼此不同,也与抗糜蛋白酶的不同。与人类抗糜蛋白酶不同,其中一种山羊抑制剂被证明是胰蛋白酶的强效特异性抑制剂(结合常数k(ass.) = 1.9×10(6) M-1·s-1),而另一种是中性粒细胞弹性蛋白酶的有效抑制剂(结合常数k(ass.) = 1.5×10(6) M-1·S-1)。每种蛋白质抑制特异性的差异很容易归因于活性位点区域内的氨基酸序列。在活性位点肽键的P1位置假定有精氨酸残基的胰蛋白酶抑制剂被称为“抗胰蛋白酶”,这表明抗胰蛋白酶并不局限于啮齿动物。相比之下,弹性蛋白酶抑制剂的抑制特异性、对氧化和蛋白水解失活的抗性以及P1亮氨酸残基的存在,在迄今已鉴定的抑制性丝氨酸蛋白酶抑制剂中是独特的。由于这种丝氨酸蛋白酶抑制剂显然是山羊血浆中的主要弹性蛋白酶抑制剂,它可能参与了山羊中性粒细胞弹性蛋白酶的调控。因此,我们建议将其命名为“弹性蛋白酶抑制素”,并将其扩展到任何其他具有中性粒细胞弹性蛋白酶抑制活性的抗糜蛋白酶相关丝氨酸蛋白酶抑制剂。